We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Integrated Pharmaceuticals Inc (CE) | USOTC:INTP | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
From Jun 2019 to Jun 2024
By Andreas Ismar
JAKARTA--PT Indocement Tunggal Prakarsa (INTP.JK) reported Monday its first half net profit rose 25% on the back of higher sales.
Indocement, in which German cement firm HeidelbergCement AG (HDELY) has majority control, posted a net profit of IDR2.17 trillion ($229 million) in the January-June period, up from IDR1.73 trillion.
Sales rose 29% to IDR8.19 trillion from IDR6.33 trillion.
The company didn't comment on its earnings.
Write to Andreas Ismar at andreasismar.sandiwan@dowjones.com
Order free Annual Report for HEIDELBERGCEMENT AG
Visit http://djnweurope.ar.wilink.com/?ticker=DE0006047004 or call +44 (0)208 391 6028
Order free Annual Report for PT INDOCEMENT TUNGGAL PRAKARSA
Visit http://djnweurope.ar.wilink.com/?ticker=ID1000061302 or call +44 (0)208 391 6028
Order free Annual Report for HEIDELBERGCEMENT AG
Visit http://djnweurope.ar.wilink.com/?ticker=US42281P2056 or call +44 (0)208 391 6028
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Integrated Pharmaceuticals (CE) Chart |
1 Month Integrated Pharmaceuticals (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
